Company Description
Cardio Diagnostics Holdings (NASDAQ: CDIOW) is a publicly traded company in the In Vitro & in Vivo Diagnostic Substances sector.
CDIOW stock has gained 34.9% over the past year. Shares last traded at $0.0178.
On a trailing twelve-month basis, Cardio Diagnostics Holdings reported revenue of $15K with net income of -$6.5M and diluted earnings per share of $-3.71. The company operates at a net profit margin of -43832.5%.
This page provides a comprehensive overview of CDIOW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cardio Diagnostics Holdings (CDIOW) stock last traded at $0.0178. Over the past 12 months, the stock has gained 34.9%.
CDIOW Rankings
Latest News
SEC Filings
Cardio Diagnostics Holdings has filed 10 recent SEC filings, including 8 Form 4, 2 Form 10-Q. The most recent filing was submitted on May 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CDIOW SEC filings →
Financial Highlights
Cardio Diagnostics Holdings generated $15K in revenue over the trailing twelve months, operating income reached -$6.5M (-43737.5% operating margin), and net income was -$6.5M, reflecting a -43832.5% net profit margin. Diluted earnings per share stood at $-3.71. The company generated -$5.7M in operating cash flow. With a current ratio of 9.79, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Cardio Diagnostics Holdings (CDIOW) currently stands at 25.2 thousand shares, up 1294.3% from the previous reporting period. Over the past 12 months, short interest has increased by 586.3%.
Days to Cover History
Days to cover for Cardio Diagnostics Holdings (CDIOW) currently stands at 2.3 days, up 132% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 132% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.3 days.
CDIOW Company Profile & Sector Positioning
Cardio Diagnostics Holdings (CDIOW) operates in the In Vitro & in Vivo Diagnostic Substances sector and is listed on the NASDAQ.